Acorns Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$366K Sell
2,517
-10
-0.4% -$1.38K ﹤0.01% 90
2026
Q2
$325K Buy
2,527
+48
+2% +$5.62K ﹤0.01% 91
2026
Q1
$298K Buy
2,479
+40
+2% +$4.62K ﹤0.01% 89
2025
Q4
$257K Sell
2,439
-10
-0.4% -$939 ﹤0.01% 93
2025
Q3
$206K Buy
+2,449
New +$202K ﹤0.01% 99

Other funds holding MRK

Acorns Advisers's MRK Position: Q3 2026 in Review

Acorns Advisers reduced its Merck (MRK) stake by 0.4% in Q3 2026, selling an estimated $1.38K and leaving 2,517 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #90.

Acorns Advisers first reported a position in MRK in Q3 2025 and has held it in 5 quarters since. 3,953 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Acorns Advisers held 2,517 shares of Merck worth $366K as of Q3 2026.
  • Acorns Advisers sold 10 Merck shares in Q3 2026, an estimated $1.38K.
  • Merck made up ﹤0.01% of Acorns Advisers's portfolio in Q3 2026, its #90 holding.
  • Acorns Advisers first reported a position in Merck in Q3 2025 and has held it in 5 quarters since.
  • 3,953 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Acorns Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.